|
2021, Vol. 30(11): 1154-1158 DOI: 10.3760/cma.j.cn113030-20210330-00127 | ||
Evaluation of clinical efficacy and safety of single-channel intracavitary applicator for uterine cervical cancer:3-year long-term results of a prospective randomized phase Ⅱ clinical trial | ||
Li Dan1, Huang Rong1, Wen En2, Wu Zhouxue1, Lin Sheng1, He Lijia1, Ren Peirong1, Shang Changling1, Xiang Li1, Yang Hongru1, Wu Jingbo1 | ||
1Department of Oncology, the Affiliated Hospital of Southwest Medical University, Luzhou 646000, China; 2Department of Oncology, First People's Hospital of Neijiang, Neijiang 641000, China |
||
Received 2021-03-30 Revised null | ||
Supporting info | ||
null | ||
|